Dr Andrew Paterson, Senior Lecturer

Dr Andrew Paterson

Senior Lecturer

From a background in physiology and pharmacology, Andrew undertook a PhD examining mitochondria in models of disease. He is particularly interested in neurophysiology and neuropharmacology and has published a number of research articles within the field.

Andrew studied for a BSc (hons) Biomedical Sciences (Pharmacology) at Aberdeen University before moving to The University of Edinburgh to undertake a PhD looking at mitochondrial status in disease models within the neurodegeneration group in the Centre for Integrative Physiology.

Andrew has worked at Leeds Beckett University for a number of years teaching across physiology and pharmacology modules within the biomedical sciences undergraduate and postgraduate courses, and other professional courses. He has been on the supervisory team of a number of PhD students working within his areas of research interest.

Current Teaching

  • BSc (Hons) Biomedical Sciences: Human Physiology (1st Year), Medical Pathophysiology (2nd year), Topics in Neuroscience (3rd Year), Project (3rd Year)
  • Biomedical Sciences MSc courses: Molecular Cell Biology and Physiology, Project
  • BSc (Hons) Speech and Language Therapy: Medical Science 1, Medical Science 2
  • BSc (hons) Nursing: Introduction to non-medical prescribing

Research Interests

Andrew uses a range cell culture approaches to investigate the effects of endogenous molecules and xenobiotics on cultured cells in vitro. Areas of current interest include:

  • Studying the role of the formyl peptide receptors (FPRs) in the nervous system, where recent work has uncovered some intruiging roles for these receptors. Further exploration of these effects may suggest novel avenues of treatment of conditions ranging from neurodegenerative diseases, neurological cancers to neuropathic pain.
  • The investigation of the cytotoxic properties of nanoparticles and their anti-cancer potential. This work involves the development and assessment of targetting ligands including antibodies and aptamers to direct nanoparticles towards cancerous cells, and could potentially be used to improve cancer diagnosis and treatment.
  • The assessment of the cytotoxicity of herbal preparations and phytochemicals which show promise as novel antimicrobials, in collaboration with Dr Margarita Gomez Escalada. This work can be used to indicate the potential of such agents in the treatment of infections and as such can be used to help direct future research effort in combating infectious diseases and antibiotic resistance.
Dr Andrew Paterson, Senior Lecturer

Ask Me About

  1. Biomedical Sciences
  2. Speech and Language Therapy
  3. Neuroscience

Selected Outputs